Combination of KRASG12C and FGFR1 inhibitors as a resistance-overcoming therapeutic strategy for maximizing therapeutic impact of KRASG12C inhibitors

被引：0
|
作者：
Santos, Alba
Plaza, Patricia
Jimenez, Marta
Gomez-Sanchez, David
Paz-Ares, Luis
Ferrer, Irene
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1930
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Exploring Targeted Degradation Strategy for Oncogenic KRASG12C
    Zeng, Mei
    Xiong, Yuan
    Safaee, Nozhat
    Nowak, Radosaw P.
    Donovan, Katherine A.
    Yuan, Christine J.
    Nabet, Behnam
    Gero, Thomas W.
    Feru, Frederic
    Li, Lianbo
    Gondi, Sudershan
    Ombelets, Lincoln J.
    Quan, Chunshan
    Janne, Pasi A.
    Kostic, Milka
    Scott, David A.
    Westover, Kenneth D.
    Fischer, Eric S.
    Gray, Nathanael S.
    CELL CHEMICAL BIOLOGY, 2020, 27 (01): : 19 - +
  • [42] Hedgehog signalling is involved in acquired resistance to KRASG12C inhibitors in lung cancer cells
    Chaeyoung Lee
    Jawoon Yi
    Jihwan Park
    Byungyong Ahn
    Young-Wook Won
    JiHeung Jeon
    Byung Ju Lee
    Wha Ja Cho
    Jeong Woo Park
    Cell Death & Disease, 15
  • [43] KRASG12C inhibition in tumor therapy
    Alakus, Hakan
    Hartmann, Milan
    Ast, David
    Bruns, Christiane
    ONKOLOGE, 2021, 27 (01): : 72 - 73
  • [44] Evaluation of KRASG12C inhibitor responses in novel murine KRASG12C lung cancer cell line models
    Sisler, Daniel J.
    Hinz, Trista K.
    Le, Anh T.
    Kleczko, Emily K.
    Nemenoff, Raphael A.
    Heasley, Lynn E.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] Inhibitors of the GTPase KRASG12C in cancer: a patent review (2019-2021)
    Xu, Qifu
    Zhang, Guozhen
    Liu, Qian
    Li, Shunda
    Zhang, Yingjie
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32 (05) : 475 - 505
  • [46] SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma
    Daley, Brianna R.
    Sealover, Nancy E.
    Finniff, Bridget A.
    Hughes, Jacob M.
    Sheffels, Erin
    Gerlach, Daniel
    Hofmann, Marco H.
    Kostyrko, Kaja
    Lamorte, Joseph P.
    Linke, Amanda J.
    Beckley, Zaria
    Frank, Andrew M.
    Lewis, Robert E.
    Wilkerson, Matthew D.
    Dalgard, Clifton L.
    Kortum, Robert L.
    CANCER RESEARCH, 2025, 85 (01) : 118 - 133
  • [47] A next-generation KRASG12C inhibitor ABSK071 demonstrated broad synergy with other therapeutic agents in KRASG12C mutated cancer models
    Ying, Haiyan
    Guo, Fushen
    Peng, Juan
    Wang, Jie
    Zhang, Jie
    Liu, Manqi
    Zhu, Zhixuan
    Chen, Zhui
    CANCER RESEARCH, 2023, 83 (08)
  • [48] Design, synthesis and bioactivity evaluation of novel quinazoline based KRASG12C inhibitors
    Liu, Qingxu
    Li, Yan
    Zhi, Ying
    Liu, Bo
    Sun, Jingyong
    NEW JOURNAL OF CHEMISTRY, 2022, 46 (10) : 4827 - 4836
  • [49] Modeling receptor flexibility in the structure-based design of KRASG12C inhibitors
    Kai Zhu
    Cui Li
    Kingsley Y. Wu
    Christopher Mohr
    Xun Li
    Brian Lanman
    Journal of Computer-Aided Molecular Design, 2022, 36 : 591 - 604
  • [50] The gRAss Is Greener: Potential new Therapies in Lung cancer with Acquired Resistance to KRAsG12c Inhibitors
    Pinnelli, Marika
    Trusolino, Livio
    CANCER DISCOVERY, 2021, 11 (08) : 1874 - 1876
12345